117 related articles for article (PubMed ID: 2579476)
1. Lack of covalent binding of peroxisome proliferators nafenopin and Wy-14 643 to DNA in vivo and in vitro.
Goel SK; Lalwani ND; Fahl WE; Reddy JK
Toxicol Lett; 1985 Jan; 24(1):37-43. PubMed ID: 2579476
[TBL] [Abstract][Full Text] [Related]
2. Detection of a nafenopin-binding protein in rat liver cytosol associated with the induction of peroxisome proliferation by hypolipidemic compounds.
Lalwani ND; Fahl WE; Reddy JK
Biochem Biophys Res Commun; 1983 Oct; 116(2):388-93. PubMed ID: 6651818
[TBL] [Abstract][Full Text] [Related]
3. Potent peroxisome proliferators inhibit beta-oxidation in the isolated perfused rat liver.
Bojes HK; Thurman RG
Toxicol Appl Pharmacol; 1996 Oct; 140(2):322-7. PubMed ID: 8887448
[TBL] [Abstract][Full Text] [Related]
4. Enantioselective activation of the peroxisome proliferator-activated receptor.
Boie Y; Adam M; Rushmore TH; Kennedy BP
J Biol Chem; 1993 Mar; 268(8):5530-4. PubMed ID: 8383673
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883.
Eacho PI; Lanier TL; Brodhecker CA
Carcinogenesis; 1991 Sep; 12(9):1557-61. PubMed ID: 1893515
[TBL] [Abstract][Full Text] [Related]
6. Malignant tumors in rats fed nafenopin, a hepatic peroxisome proliferator.
Reddy JK; Rao MS
J Natl Cancer Inst; 1977 Dec; 59(6):1645-50. PubMed ID: 200757
[TBL] [Abstract][Full Text] [Related]
7. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.
Marsman DS; Cattley RC; Conway JG; Popp JA
Cancer Res; 1988 Dec; 48(23):6739-44. PubMed ID: 3180084
[TBL] [Abstract][Full Text] [Related]
8. Enhancement by peroxisome proliferators of the susceptibility to DNA damage in the liver of male F344 rats.
Hayashi F; Tamura H; Watanabe T; Suga T
Cancer Lett; 1995 May; 92(1):87-90. PubMed ID: 7757964
[TBL] [Abstract][Full Text] [Related]
9. Effect of peroxisome proliferators on intrachromosomal and interchromosomal recombination in yeast.
Schiestl RH; Reddy JK
Carcinogenesis; 1990 Jan; 11(1):173-6. PubMed ID: 2403857
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferators activate Kupffer cells in vivo.
Bojes HK; Thurman RG
Cancer Res; 1996 Jan; 56(1):1-4. PubMed ID: 8548746
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster.
Lake BG; Evans JG; Cunninghame ME; Price RJ
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):241-7. PubMed ID: 8013414
[TBL] [Abstract][Full Text] [Related]
12. Induction of peroxisomal enzymes in livers of neonatal rats exposed to lactating mothers treated with hypolipidaemic drugs. Role of drug metabolite transfer in milk.
Fahl WE; Lalwani ND; Reddy MK; Reddy JK
Biochem J; 1983 Mar; 210(3):875-83. PubMed ID: 6683505
[TBL] [Abstract][Full Text] [Related]
13. Use of primary cultures of adult rat hepatocytes to investigate mechanisms of action of nafenopin, a hepatocarcinogenic peroxisome proliferator.
Bieri F; Bentley P; Waechter F; Stäubli W
Carcinogenesis; 1984 Aug; 5(8):1033-9. PubMed ID: 6146407
[TBL] [Abstract][Full Text] [Related]
14. Specific changes in the protein composition of rat liver in response to the peroxisome proliferators ciprofibrate, Wy-14,643 and di-(2-ethylhexyl)phthalate.
Watanabe T; Lalwani ND; Reddy JK
Biochem J; 1985 May; 227(3):767-75. PubMed ID: 4004798
[TBL] [Abstract][Full Text] [Related]
15. Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet.
Lalwani ND; Reddy MK; Qureshi SA; Reddy JK
Carcinogenesis; 1981; 2(7):645-50. PubMed ID: 7273344
[TBL] [Abstract][Full Text] [Related]
16. Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14, 643), in rat and mouse liver.
Reddy JK; Rao MS; Azarnoff DL; Sell S
Cancer Res; 1979 Jan; 39(1):152-61. PubMed ID: 83907
[No Abstract] [Full Text] [Related]
17. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver.
Cattley RC; Popp JA
Cancer Res; 1989 Jun; 49(12):3246-51. PubMed ID: 2566380
[TBL] [Abstract][Full Text] [Related]
18. Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis.
James NH; Roberts RA
Carcinogenesis; 1996 Aug; 17(8):1623-32. PubMed ID: 8761418
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of the hepatocarcinogenesis caused by dehydroepiandrosterone, a peroxisome proliferator, in male F-344 rats.
Hayashi F; Tamura H; Yamada J; Kasai H; Suga T
Carcinogenesis; 1994 Oct; 15(10):2215-9. PubMed ID: 7955056
[TBL] [Abstract][Full Text] [Related]
20. Effects of the hepatocarcinogen nafenopin, a peroxisome proliferator, on the activities of rat liver glutathione-requiring enzymes and catalase in comparison to the action of phenobarbital.
Furukawa K; Numoto S; Furuya K; Furukawa NT; Williams GM
Cancer Res; 1985 Oct; 45(10):5011-9. PubMed ID: 2862989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
